Video Latest - ecancer

WIN Symposium 2014: Breakthrough biomarker investigations and combination therapies

Dr John Mendelsohn, Dr Razelle Kurzrock, Dr Mace Rothenberg

6 May 2014

Work and history of the Kidney Cancer Association

Carrie Konosky - Vice President of Development & Public Affairs, Kidney Cancer Association, Chicago, USA

6 May 2014

Kidney cancer treatment ten years from now

Prof Martin Gore - The Royal Marsden Hospital, London, UK

6 May 2014

Personalisation of leukaemia treatment using genome sequencing

Dr Giovanni Martinelli - University of Bologna, Bologna, Italy

5 May 2014

New drug OTX15 shows early promise in fighting acute myeloid leukaemia

Dr Esteban Cvitkovic - Oncoethix, Lausanne, Switzerland

5 May 2014

History and ongoing work of AORTIC

Dr James Holland - Mount Sinai Hospital, New York, USA

5 May 2014

AORTIC and the benefits of coordination between different US NCI-designated cancer centres in Kenya

Dr Lisa Stevens - National Cancer Institute, Bethesda, USA

5 May 2014

Subset of breast cancer patients found to benefit from neratinib in latest trial

Dr John W. Park - University of California San Francisco, San Francisco, USA

1 May 2014

Phase II trial shows dacomitinib benefits a subgroup of patients with head and neck cancer

Dr Byoung Chul Cho - Yonsei University College of Medicine, Seoul, Republic of Korea

1 May 2014

Phase I trial shows the benefits of OTX015 in treating blood cancer

Dr Esteban Cvitkovic - Oncoethix, Lausanne, Switzerland

1 May 2014

"Exciting" implications of bemacyclib study in the treatment of breast cancer

Dr Amita Patnaik - South Texas Accelerated Research Therapeutics, San Antonio, USA

1 May 2014

Immunotherapy in melanoma

Dr Adil I. Daud - University of California San Francisco School of Medicine, San Francisco, USA

1 May 2014

Video